• We provide below a curated overview of the most relevant instruments supporting patents, trademarks, designs, and early-stage IP strategy, complete with application timelines and official links for direct execution by founders and SMEs.

    Denmark

    DKPTO SME voucher (Patentvoucher and Startpakker)

    Supports patent drafting, prior-art searches, IP strategy development, and official filings.

    • Coverage: Up to 75% of costs, maximum DKK 75,000 per year.

    • Timeline: Rolling applications; funds available until the annual budget is exhausted.

    • Official Link: https://www.dkpto.dk

    EUopSTART (Horizon Europe & EDF)

    Funding for Danish SMEs preparing proposals for the EU Defence Fund or Horizon Europe. IP-related costs incurred during proposal preparation are eligible.

    • 2026 Deadlines:

      • February 27, 2026, 12:00 CET

      • May 29, 2026, 12:00 CET

      • August 28, 2026, 12:00 CET

      • November 4, 2026, 12:00 CET

    • Official Link: https://ufm.dk (via e-grant portal)

    European Union

    EUIPO SME Fund 2026

    Reimbursement for costs associated with patents, trademarks, designs, plant varieties, and IP scans.

    • Application window: February 2, 2026 → December 4, 2026

    • Activation: Vouchers must be activated within 1 month (extendable to 2 months).

    • Note: First-come, first-served basis; early application is strongly recommended.

    • Official Link: https://euipo.europa.eu

    Eurostars (Eureka Network)

    Supports international R&D collaborations. Patenting and IP protection costs can be integrated into project budgets.

    Nordics

    Explore specific support instruments available in Sweden, Norway, and Finland.

    Sweden: PRV SME Support

    Swedish SMEs can access funding for IP scans, patentability assessments, and early-stage IP strategy development.

    Norway: Patentstyret SME Support

    While Norway does not offer a dedicated SME voucher scheme identical to the EUIPO, Norwegian SMEs can leverage:

    • National support instruments (e.g., Innovation Norway programmes).

    • Patentstyret provides comprehensive IP services and guidance; funding options vary by programme.

    • Official Link: https://www.patentstyret.no

    Finland: Business Finland Innovation Voucher

    Can be utilized for IP consulting, various protection activities, and early strategic IP assessments.

    • Voucher Value: €6,000 (100% funding of expert services, excluding VAT).

    • Timeline: Rolling calls; subject to annual budget availability.

    • Official Link: https://www.businessfinland.fi

    Navigate your IP protection journey with confidence. Need expert guidance in securing these funding opportunities or developing a robust IP strategy tailored to your innovation?

    Contact Elevate IP Advisory for a personalized consultation today. Email us at ek@elevateipadvisory.com.


  • At ELEVATE IP, we apply a disciplined, cross‑jurisdictional approach to due diligence, ensuring that disclosures are accurate, proportionate, and fully aligned with US and EP best practice. Our focus is simple: protect value, preserve privilege, and maintain control of the narrative throughout the transaction.

    Curated, controlled data rooms

    We ensure that data rooms remain intentionally lean. Only final, non‑sensitive documents required for diligence are uploaded. All materials undergo legal and business review before inclusion.

    Strict access management

    We implement tiered, need‑to‑know access with time‑limited permissions and active audit logging. Sensitive folders are segregated, and access is granted progressively as diligence advances.

    Protection of privilege

    We never upload materials that risk privilege waiver under US attorney–client rules or that fall outside the scope of legal professional privilege in Europe.

    Oral handling of sensitive issues

    Matters such as IP ownership gaps, contract anomalies, etc is addressed verbally in a controlled setting. We avoid creating written summaries or analyses that could be misinterpreted or broaden disclosure obligations.

  • ELEVATE IP understands that the true value of EU Free Trade Agreements (FTAs) for innovators extends far beyond conventional tariff reductions. These agreements are pivotal in reshaping the global intellectual property (IP) and regulatory landscape, ensuring European innovation competes on strength and merit, rather than facing uneven playing fields. With several landmark agreements recently concluded or entering into force, 2026 marks a dynamic period for IP protection and market access.

    Key FTAs Driving IP & Regulatory Evolution

    Our analysis highlights the critical impact of recent EU FTAs on patent-term extensions, regulatory clarity, and the harmonization of trade-secret frameworks:

    • EU–India FTA (Concluded January 2026): Significantly strengthens trade-secret harmonization, expands Geographical Indication (GI) protection, and deepens regulatory cooperation. Discussions included vital provisions for regulatory data protection and clearer pathways for biosimilars and generics, fostering a more predictable market environment.

    • EU–Mercosur (Political Agreement Reached January 2026): Delivers one of the most comprehensive GI packages ever negotiated, reinforcing enforcement mechanisms and aligning crucial trade-secret rules. While not introducing patent-term extensions, it brings substantial improvements in regulatory transparency and IP procedural efficiency.

    • EU–New Zealand FTA (Signed July 2023, Entered into Force May 2024): Modernizes digital copyright provisions, expands GI protection, and strengthens anti-counterfeiting measures. It also establishes clearer regulatory cooperation frameworks for innovative medicines and generics, promoting both innovation and access.

    • EU–Chile Advanced Framework Agreement (Concluded December 2022, Signed December 2023): Updates digital IP rules, fortifies enforcement, broadens GI protection, and enhances regulatory cooperation across innovation-intensive sectors, future-proofing IP frameworks.

    • EU–Mexico Modernised Agreement (Negotiations Concluded April 2020, Ratification Ongoing): Enhances GI protection, modernizes enforcement, updates digital-era IP rules, and clarifies regulatory pathways for medicines without introducing patent-term extensions, ensuring a balanced approach.

    • EU–Vietnam FTA (EVFTA) (In Force August 2020, Phased Implementation through 2024–2025): A cornerstone agreement introducing patent-term extensions for pharmaceuticals, improving regulatory data protection, strengthening GI protection, and upgrading enforcement capabilities.

    • CETA (EU–Canada) (Provisionally In Force Since September 2017): Pioneered Canada’s first Certificate of Supplementary Protection (CSP) for patent-term restoration. Expanded GI protection, strengthened enforcement, and improved regulatory data protection frameworks, setting a precedent for future agreements.

    Why This Matters for European Innovators

    These strategically negotiated FTAs are instrumental in:

    • Strengthening R&D Incentives: Patent-term extensions and robust regulatory data protection directly enhance the commercial viability of long-cycle research and development across sectors.

    • Enhancing Market Predictability: Clearer pathways for generics and biosimilars reduce market uncertainty, fostering well-regulated competition that ultimately benefits consumers and innovators.

    • Protecting Next-Generation IP: Harmonized trade-secret rules are indispensable for safeguarding proprietary knowledge in rapidly evolving fields such as AI, biotechnology, and advanced manufacturing.

    • Safeguarding European Assets: Stronger enforcement mechanisms and expanded GI protection provide essential safeguards for Europe's premium products and intellectual assets.

    These agreements transcend mere trade facilitation; they strategically extend the reach of the EU's regulatory model, ensuring global markets operate on standards that inherently reward quality, safety, and ground-breaking innovation.

    For an innovation-driven Europe, these FTAs are not merely trade instruments; they are critical strategic infrastructure that protects intellectual capital, reinforces global competitiveness, and ensures European innovation thrives on the world stage.